CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company is headquartered in Saratoga, California.
| Revenue (TTM) | $13.56M |
| Gross Profit (TTM) | $7.01M |
| EBITDA | $-26.85M |
| Operating Margin | -254.10% |
| Return on Equity | -185.10% |
| Return on Assets | -88.10% |
| Revenue/Share (TTM) | $0.38 |
| Book Value | $0.41 |
| Price-to-Book | 16.33 |
| Price-to-Sales (TTM) | 24.39 |
| EV/Revenue | 23.09 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.30% |
| Shares Outstanding | $49.96M |
| Float | $31.41M |
| % Insiders | 32.09% |
| % Institutions | 8.15% |
Volatility is currently contracting
SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, announced the appointment of David S.
SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results for its first quarter ended March 31, 2026.
SARATOGA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the Company will release first quarter 2026 financial results on Thursday, May 14, 2026, after the close of market. CapsoVision will host a corresponding conference call and a live webcast at 1:30 pm PT / 4:30 pm ET on the same day to discuss the results and provide a corporate update.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CV and any ticker you trade — then tracks every position and per-strategy win rate.
